Travel Medicine and Infectious Disease
Volume 1, Issue 2 , Pages 80-88 , May 2003

Cholera: assessing the risk to travellers and identifying methods of protection

  • Robert Steffen

      Affiliations

    • Institute for Social and Preventive Medicine (ISPM), WHO Collaboration Centre for Travellers' Health, University of Zurich, Sumatrastrasse 30, Zurich CH-8006, Switzerland
    • Corresponding Author InformationCorresponding author. Tel.: +41-1-634-4620; fax: +41-1-634-4984
    • ,
  • Jacques Acar

      Affiliations

    • Pierre et Marie Curie University, Paris, France
    • ,
  • Eric Walker

      Affiliations

    • Scottish Centre for Infection and Environmental Health, Glasgow, Scotland, UK
    • ,
  • Jane Zuckerman

      Affiliations

    • Royal Free and University College Medical Centre, London, UK

Received 9 June 2003 ,Revised 12 June 2003 ,Accepted 12 June 2003.

References 

  1. WHO. Cholera, 2001. Wkly Epidemiol Rec. 2002;77(31):257–268
  2. WHO. Cholera vaccines. WHO position paper. Wkly Epidemiol Rec. 2001;76(16):117–124
  3. CDC/NCID. Laboratory methods for the diagnosis of epidemic dysentery abd cholera. Atlanta. 1999;37–40
  4. Sack D, Cadoz M. Cholera vaccines. In:  Plotkin SA,  Orenstein WA editor. Vaccines. Philadephia: W. B. Saunders Company; 1999;p. 639–649
  5. Holmgren J. Actions of cholera toxin and the prevention and treatment of cholera. Nature. 1981;292(5822):413–417
  6. Holmgren J, Jertborn M, Svennerholm A. New and improved vaccines against cholera. In:  Levine MM, et al. editor. New generation vaccines. New york: Marcel Dekker; 1997;p. 459–468
  7. WHO. Cholera. Cholera. Geneva: WHO; 2000; Chapter 4, pp 39–43
  8. Goma Epidemiology Group. Public health impact of Rwandan refugee crisis: what happened in Goma, Zaire, in July, 1994?. Lancet. 1995;345(8946):339–344
  9. WHO, Cholera Fact Sheet, http://www.who.int/inf-fs/en/fact107.html, 2000.
  10. WHO, Potential use of oral cholera vaccines in emergency situations: Report of a WHO meeting, 12–13 May 1999, www.who.int/emc, World Health Organisation, 1999.
  11. Siddique AK, et al.  Cholera epidemics in Bangladesh: 1985–1991. J Diarrhoeal Dis Res. 1992;10(2):79–86
  12. WHO. Cholera in 1991. Wkly Epidemiol Rec. 1992;67:253–260
  13. WHO, Cholera Reporting: International Health regulations, http://www.who.int/csr/disease/cholera/ihrnotification/en/, 2003.
  14. WHO, Cholera in Iraq-Update, http://www.who.int/csr/don/2003_05_14/en/, 2003.
  15. WHO, Cholera in Iraq, http://www.who.int/csr/don/2003_05_08a/en/, 2003.
  16. WHO, Cholera in Iraq-Update, http://www.who.int/csr/don/2003_05_13a/en/, 2003.
  17. Wittlinger F, et al.  Risk of cholera among western and japanese travelers. J Travel Med. 1995;2(3):154–158
  18. Gradon JD, et al.  The fortuitous diagnosis of cholera in a two-year-old girl. Diagn Microbiol Infect Dis. 1992;15(2):161–164
  19. CDC, Summary of notifiable diseases, United States, Morbidity and Mortality Weekly Report, 47, 90–92, 1999.
  20. WHO. Cholera in 1995. Wkly Epidemiol Rec. 1996;71(21):157–164
  21. WHO. Cholera in 1996. Wkly Epidemiol Rec. 1997;72(31):229–236
  22. WHO. Cholera in 1997. Wkly Epidemiol Rec. 1998;73(27):201–208
  23. WHO. Cholera, 1998. Wkly Epidemiol Rec. 1999;74(31):257–264
  24. WHO. Cholera, 1999. Wkly Epidemiol Rec. 2000;75(31):249–256
  25. WHO. Cholera, 2000. Wkly Epidemiol Rec. 2001;76(31):233–240
  26. Sanchez JL, Taylor DN. Cholera. Lancet. 1997;349(9068):1825–1830
  27. Taylor DN, et al.  Cholera among Americans living in Peru. Clin Infect Dis. 1996;22(6):1108–1109
  28. Weber JT, Levine WC, Hopkins DP, Tauxe RV. Cholera in the United States, 1965–1991: risks at home and abroad. Arch Intern Med. 1994;154:551–556
  29. Ryan ET, Calderwood SB. Cholera vaccines. J Travel Med. 1994;8(2):82–91
  30. Burkhardt U, Blessing J, Langbein G. Importation of cholera from Turkey. Case report of cholera acquired in Istanbul. Fortschr Med. 1996;114(35–36):485–487
  31. Dalsgaard A, et al.  The first case of Vibrio cholerae 0139 in Denmark. Ugeskr Laeger. 1996;158(37):5169–5171
  32. Gaudio PA, et al.  Diarrhea among expatriate residents in Thailand: correlation between reduced campylobacter prevalence and longer duration of stay. J Travel Med. 1996;3(2):77–79
  33. Lange KH, et al.  Cholera in Denmark—an imported case of illness. Ugeskr Laeger. 1995;157(16):2325–2326
  34. Sharma TK, et al.  Cholera gravis caused by Vibrio cholerae O139, a novel, imported pathogen. Clin Infect Dis. 1995;21(1):241–242
  35. Smit AA, et al.  2 Dutch travelers returning from Thailand with cholera. Ned Tijdschr Geneeskd. 1994;138(17):871–873
  36. Ueda Y, et al.  Bacteriological studies of traveller's diarrhoea (6). Analysis of enteropathogenic bacteria at Kansai Airport Quarantine Station from September 4th, 1994 through December 1996. Kansenshogaku Zasshi. 1999;73(2):110–121
  37. Guerrant RL. Gastrointestinal infections and food poisoning. In:  Mandell GL,  Bennett JE,  Dolin R editor. Principles and practice of infectious disease. New York: Churchill Livingstone; 1995;p. 945–962
  38. Mudur G. Drug resistant cholera in India attributed to antibiotic misuse. BMJ. 2000;321(7273):1368
  39. Rakoto Alson AO, et al.  Vibrio cholerae in Madagascar: study of a multiresistant strain. Arch Inst Pasteur Madagascar. 2001;67(1–2):6–13
  40. Melano R, et al.  New carbenicillin-hydrolyzing beta-lactamase (CARB-7) from Vibrio cholerae non-O1, non-O139 strains encoded by the VCR region of the V. cholerae genome. Antimicrob Agents Chemother. 2002;46(7):2162–2168
  41. Mazel D, et al.  A distinctive class of integron in the Vibrio cholerae genome. Science. 1998;280(5363):605–608
  42. Baranwal S, et al.  Role of active efflux in association with target gene mutations in fluoroquinolone resistance in clinical isolates of Vibrio cholerae. Antimicrob Agents Chemother. 2002;46(8):2676–2678
  43. Clemens JD, et al.  Field trial of oral cholera vaccines in Bangladesh. Lancet. 1986;2(8499):124–127
  44. Clemens JD, et al.  Field trial of oral cholera vaccines in Bangladesh: results of one year of follow-up. J Infect Dis. 1988;158(1):60–69
  45. van Loon FP, et al.  Field trial of inactivated oral cholera vaccines in Bangladesh: results from 5 years of follow-up. Vaccine. 1996;14(2):162–166
  46. Sanchez JL, et al.  Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruits. Lancet. 1994;344(8932):1273–1276

  47. TRAVAX http://www.travax.scot.nhs.uk/

  48. Deutsche Gesellschaft für tropenmedizin und Internationale Gesundheit e.V, http://www.dtg.mwn.de

  49. CDC http://www.cdc.gov/travel/cholera.htm

  50. Canada communicable disease report http://www.hc-sc.gc.ca/pphb-dgspsp/tmp-pmv/info/cholera_e.html, 1998

  51. Kilhamn J, et al.  Immune responses in ileostomy fluid and serum after oral cholera vaccination of patients colectomized because of ulcerative colitis. Infect Immun. 1998;66(8):3995–3999
  52. Ortigao-de-Sampaio MB, et al.  Increase in plasma viral load after oral cholera immunization of HIV-infected subjects. Aids. 1998;12(14):F145–F150
  53. Eriksson K, et al.  Intestinal antibody responses to oral vaccination in HIV-infected individuals. Aids. 1993;7(8):1087–1091
  54. Friman V, et al.  Intestinal and circulating antibody-forming cells in IgA-deficient individuals after oral cholera vaccination. Clin Exp Immunol. 1994;95(2):222–226

PII: S1477-8939(03)00062-0

doi: 10.1016/S1477-8939(03)00062-0

Travel Medicine and Infectious Disease
Volume 1, Issue 2 , Pages 80-88 , May 2003

Article Tools

* Image Usage & Resolution